Diabetes and Alzheimer's disease: Can Elevated Free Copper Predict the Risk of the Disease?

Manuscript Number: 

16-1033R2

Author(s): 
Armando J. Mendez, Camillo Ricordi, Ilaria Simonelli, Rosanna Squitti

Disclosures

Armando J. Mendez

  • Nothing to Disclose

Camillo Ricordi

  • Consulting Fees:
    Zone Labs, Inc - Scientific Advisory Board Semma Therapeutics - Scientific Advisory Board
    Equity:
    Converge Biotech, Inc. - 6% equity, but does not receive monetary compensation Ophysio, Inc. - 5% equity, but does not receive monetary compensation
    Patents/Royalties
    Patents related to islet cell processing technologies. I receive no royalties for these patents.

Ilaria Simonelli

  • Nothing to Disclose

Rosanna Squitti

  • Consulting Fees:
    consulting fee
    Equity:
    3% shares in Canox4drug; 3% shares in Igeaa Research Corporation
    Patents/Royalties
    I have scientific paternity but not commercial ownwship of 2 patents: 1) Colabufo, N. and Squitti R, METHOD AND KIT FOR DETERMINATION OF FREE COPPER IN SERUM, International publication number WO2014/071973A1 2) Colabufo N, Berardi F, Leopoldo M, Perrone R, and Squitti R, METHOD FOR DETERMINING FREE COPPER, International publication number WO2014/181215A2